Avita Medical – Data Demonstrating ReCell® Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology

/in ,

6 July 2015. Link here for ASX announcement. Demonstrates 78% Repigmentation compared to 0% in Control Groups.

Read more

Avita Medical – Chronic wound RCT scoops Innovation Prize at Skin Regeneration Symposium

/in ,

Cambridge, 21st April 2015 —Published results from a randomized control clinical trial that used Avita Medical’s skin regenerating device to successfully treat chronic wounds have won the lead clinician the ‘Avita Medical prize for Innovation’, the company announced today…. Read more.

Read more

Avita Medical Appoints Adam Kelliher as Chief Executive Officer

/in ,

ASX | News Release Avita Medical  Appoints Adam Kelliher as Chief Executive Officer Australia 14 April  201 5 — Avita Medical Ltd.  (ASX: AVH ), (OTCQX: AVMXY), a regenerative medicine  company specializing in the treatment of wounds and skin defects, today announced the appointment  of  Mr. Adam Kelliher as Chief Executive Officer. Tim Rooney, who […]

Read more

Avita Announces $A5M Placement and Initiates Share Purchase Plan

/in ,

Northridge, CA and Cambridge, UK, 11 March 2015 – Link here. Avita Medical Ltd (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today the closing of a placement to sophisticated and institutional investors and launched a Share Purchase Plan (“SPP”). The placement raised $A5,042,280.00 through the issuance […]

Read more

Avita Medical Announces First Patient Enrolment in US Pivotal Study of ReCell® for the Treatment of Burns

/in ,

Northridge, CA and Cambridge, UK, 28 January 2015. Link here. Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company’s Pivotal Phase III burn trial for ReCell®. The FDA-approved study is designed to confirm the safety and […]

Read more